文献速递乳腺病理细胞病理与分子病理

CHEK2基因外显子8和10可变剪接综合分析揭示三个富集增强子/沉默子区域及38个剪接致病变异

Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer-rich regions and 38 spliceogenic variants.
PubMed 文献 · J Pathol · 2024-02-09

本研究利用包含CHEK2外显子6-10的小基因模型,在MCF-7细胞中通过剪接试验定位外显子8和10的剪接调控元件富集区,并功能验证87个变异,发现38个(44%)影响剪接,其中4个几乎完全破坏剪接,3个被ACMG/AMP分类为致病/可能致病。

要点

  • CHEK2外显子8和10存在三个关键剪接调控区域,微缺失可导致外显子跳跃。
  • c.883G>A、c.883G>T和c.884A>T被ACMG/AMP分类为致病/可能致病。

核心结论

  • CHEK2外显子8和10的剪接调控区域鉴定出38个剪接致病变异,其中3个被分类为致病/可能致病。

研究设计与样本

  • 使用先前发表的小基因(外显子6-10)在MCF-7细胞中进行剪接试验,通过12个内部微缺失定位剪接调控元件富集区,并对87个变异进行功能测试。

主要发现

  • 三个最小区域(10、11、15个核苷酸)对exon识别至关重要:c.863_877del导致Δ(E8) 75%,c.1073_1083del导致Δ(E10) 97%,c.1083_1092del导致Δ(E10) 62%。
  • 87个变异中38个(44%)损害剪接,其中4个(c.883G>A、c.883G>T、c.884A>T、c.1080G>T)产生的小基因全长转录本不足5%。
  • 另6个变异(c.886G>A、c.886G>T、c.1075G>A、c.1075G>T、c.1076A>T、c.1078G>T)显示显著强影响(小基因全长转录本的20-50%)。
  • c.883G>A、c.883G>T和c.884A>T根据ACMG/AMP标准分类为致病/可能致病。

关键数值与推荐

  • 外显子8关键区域:c.863_877del导致Δ(E8) 75%。
  • 外显子10关键区域:c.1073_1083del导致Δ(E10) 97%,c.1083_1092del导致Δ(E10) 62%。
  • 4个变异产生<5%小基因全长转录本:c.883G>A、c.883G>T、c.884A>T、c.1080G>T。
  • 6个变异产生20-50%小基因全长转录本:c.886G>A、c.886G>T、c.1075G>A、c.1075G>T、c.1076A>T、c.1078G>T。

临床怎么用

  • 对于CHEK2外显子8和10的变异,应进行剪接功能分析以评估其致病性。
  • 同义和错义变异也可能通过影响剪接而致病,需结合剪接试验解读。
  • ACMG/AMP分类为致病/可能致病的剪接变异可用于临床风险咨询。

局限性

  • 研究仅使用MCF-7细胞和小基因模型,可能不完全反映体内剪接。
  • 未报告其他细胞类型或体内验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Splicing is controlled by a large set of regulatory elements (SREs) including splicing enhancers and silencers, which are involved in exon recognition. Variants at these motifs may dysregulate splicing and trigger loss-of-function transcripts associated with disease. Our goal here was to study the alternatively spliced exons 8 and 10 of the breast cancer susceptibility gene CHEK2. For this purpose, we used a previously published minigene with exons 6-10 that produced the expected minigene full-length transcript and replicated the naturally occurring events of exon 8 [Δ(E8)] and exon 10 [Δ(E10)] skipping. We then introduced 12 internal microdeletions of exons 8 and 10 by mutagenesis in order to map SRE-rich intervals by splicing assays in MCF-7 cells. We identified three minimal (10-, 11-, 15-nt) regions essential for exon recognition: c.863_877del [ex8, Δ(E8): 75%] and c.1073_1083del and c.1083_1092del [ex10, Δ(E10): 97% and 62%, respectively]. Then 87 variants found within these intervals were introduced into the wild-type minigene and tested functionally. Thirty-eight of them (44%) impaired splicing, four of which (c.883G>A, c.883G>T, c.884A>T, and c.1080G>T) induced negligible amounts (<5%) of the minigene full-length transcript. Another six variants (c.886G>A, c.886G>T, c.1075G>A, c.1075G>T, c.1076A>T, and c.1078G>T) showed significantly strong impacts (20-50% of the minigene full-length transcript). Thirty-three of the 38 spliceogenic variants were annotated as missense, three as nonsense, and two as synonymous, underlying the fact that any exonic change is capable of disrupting splicing. Moreover, c.883G>A, c.883G>T, and c.884A>T were classified as pathogenic/likely pathogenic variants according to ACMG/AMP (American College of Medical Genetics and Genomics/Association for Molecular Pathology)-based criteria. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

来源:J Pathol,查看原文。版权归原作者所有。

引用

  1. Sanoguera-Miralles L, Llinares-Burguet I, Bueno-Martínez E, et al. Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer-rich regions and 38 spliceogenic variants. J Pathol. 2024. PMID: 38332730. doi:10.1002/path.6243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。